表紙
市場調查報告書

全球人工授精市場 - 規模,佔有率及趨勢:各最終用途(家庭、不孕治療診所以及其他的設施)、類型(子宮內、陰道內)、提供來源(AIH、AID)、市場區隔預測(2019年∼2026年)

Artificial Insemination Market Size, Share & Trends Analysis Report By End Use (Home, Fertility Clinics & Other Facilities), By Type (Intrauterine, Intravaginal), By Source Type (AIH, AID), And Segment Forecasts, 2019 - 2026

出版商 Grand View Research, Inc. 商品編碼 656111
出版日期 內容資訊 英文 100 Pages
商品交期: 2-3個工作天內
價格
Back to Top
全球人工授精市場 - 規模,佔有率及趨勢:各最終用途(家庭、不孕治療診所以及其他的設施)、類型(子宮內、陰道內)、提供來源(AIH、AID)、市場區隔預測(2019年∼2026年) Artificial Insemination Market Size, Share & Trends Analysis Report By End Use (Home, Fertility Clinics & Other Facilities), By Type (Intrauterine, Intravaginal), By Source Type (AIH, AID), And Segment Forecasts, 2019 - 2026
出版日期: 2019年06月24日內容資訊: 英文 100 Pages
簡介

全球人工授精市場在2019年∼2026年間,預測將以8.4%的年複合成長率成長,2026年達到29億美元的規模。

本報告提供全球人工授精市場的相關調查,市場變動和趨勢,各類型、最終用途、提供來源、地區的市場分析,競爭情形,主要企業簡介等資訊。

目錄

第1章 調查方法及範圍

  • 市場區隔及範圍
  • 調查方法
  • 資訊採購
  • 資訊或資料分析
  • 市場制定及檢驗
  • 模式詳細內容
  • 第二手資料的清單
  • 目的

第2章 摘要整理

  • 市場預測
  • 市場區隔預測
  • 競爭的洞察

第3章 市場變動,趨勢及範圍

  • 市場區隔
  • 洞察及成長預測的製圖
  • 商務環境分析工具

第4章 市場分析:各類型

  • 市場佔有率分析(2018年&2026年)
  • 市場區隔儀表板
  • 市場規模,預測及趨勢分析(2015年∼2026年)

第5章 市場分析:各最終用途

  • 市場佔有率分析(2018年&2026年)
  • 市場區隔儀表板
  • 市場規模,預測及趨勢分析(2015年∼2026年)

第6章 市場分析:各提供來源

  • 市場佔有率分析(2018年&2026年)
  • 市場區隔儀表板
  • 市場規模,預測及趨勢分析(2015年∼2026年)

第7章 市場分析:各地區

  • 市場佔有率分析(2018年&2026年)
  • 市場區隔儀表板
  • 市場概述(市場規模,年複合成長率,主要產業,主要企業,主要趨勢)
  • 市場規模,預測及趨勢分析(2015年∼2026年)

第8章 競爭情形

  • 策略性架構/競爭的分類(主要創新者,市場領導者,新興企業
  • 企業簡介

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GVR-2-68038-176-4

The global artificial insemination market size is expected to reach USD 2.9 billion by 2026 registering a CAGR of 8.4%, according to a new report by Grand View Research, Inc. Over the past few years, infertility has become a major public health concern across the globe. Artificial insemination is usually the preferred first-line treatment to tackle infertility. Lifestyle changes, delay in pregnancy, and hormonal issues are some of the reasons contributing to the rise in fertility-related problems. According to the United Nations, the global fertility rate is expected to decline to 2.2% by 2050. In developing or underdeveloped nations, medical consultation regarding infertility was not easily accessible.

Hence, there was a lack of awareness about available assisted reproductive techniques including artificial or donor insemination and IVF. The average cost of performing an IUI is around USD 865. The success rate for each cycle is around 4 to 5%, which can be increased to about 7 to 16% by consuming fertility drugs. However, older women are not encouraged to go through IUI due to slim chances of success and further complications. Several fertility problems can be addressed through IUI, such as semen allergy, unexplained infertility, and Sexually Transmitted Diseases (STDs).

Further key findings from the study suggest:

  • Artificial insemination is a first-line of infertility treatment, as it is minimally invasive and less expensive as compared to IVF
  • In some countries, such as U.S. and U.K., same-sex couples are provided insurance coverage for artificial insemination procedures
  • Intrauterine insemination held majority of the market share in 2018 and is likely to be the fastest-growing segment over the forecast period as it is the most common and non-invasive procedure
  • Fertility clinics held a majority of the market share in the year 2018 due to higher number of medical facilities offering infertility treatments
  • Europe held a majority of the market share in the year 2018. North America was the second-largest market in 2018

Some of the key companies in the global artificial insemination market include: Vitrolife; Genea Ltd.; Rinovum Women's Health, LLC; Pride Angel; Hi-Tech Solutions; FUJIFILM Irvine Scientific; Kitazato Corp.; and Rocket Medical plc.

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Type
    • 1.1.2 End Use
    • 1.1.3 Source Type
    • 1.1.4 Regional Scope
    • 1.1.5 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR'S Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
    • 1.6.2 Volume Price Analysis (Model 2)
  • 1.7 List of Secondary Sources
  • 1.8 Objectives
    • 1.8.1 Objective - 1
    • 1.8.2 Objective - 2

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
    • 2.2.1 Type
    • 2.2.2 End Use
    • 2.2.3 Source Type
    • 2.2.4 Region
  • 2.3 Competitive Insights

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Segmentation
  • 3.2 Penetration & Growth Prospect Mapping
    • 3.2.1 Penetration Analysis
    • 3.2.2 Market Driver Analysis
      • 3.2.2.1 Constant rise in infertility rate
      • 3.2.2.2 Growing awareness and social acceptance of assisted reproductive technologies
      • 3.2.2.3 Single women and same-sex couples prefer artificial insemination
    • 3.2.3 Market Restraint Analysis
      • 3.2.3.1 Unsupportive government regulations in certain areas
  • 3.3 Artificial insemination Market: Business Environment Analysis Tools

Chapter 4 Artificial Insemination Market: Type Analysis

  • 4.1 Artificial Insemination Type Market Share Analysis, 2018 & 2026
  • 4.2 Artificial insemination Type Market: Segment Dashboard:
  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Type Segment
    • 4.3.1 Intrauterine Insemination
      • 4.3.1.1 Intrauterine insemination market, 2015 - 2026 (USD Million)
    • 4.3.2 Intracervical Insemination
      • 4.3.2.1 Intracervical insemination market, 2015 - 2026 (USD Million)
    • 4.3.3 Intravaginal Insemination
      • 4.3.3.1 Intravaginal insemination market, 2015 - 2026 (USD Million)
    • 4.3.4 Intratubal Insemination
      • 4.3.4.1 Intratubal insemination market, 2015 - 2026 (USD Million)

Chapter 5 Artificial Insemination Market: End Use Analysis

  • 5.1 Artificial Insemination End Use Market Share Analysis, 2018 & 2026
  • 5.2 Artificial insemination End Use Market: Segment Dashboard:
  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the End Use Segment
    • 5.3.1 Fertility Clinics & Other Facilities
      • 5.3.1.1 Fertility clinics & other facilities Facilities market, 2015 - 2026 (USD Million)
    • 5.3.2 HOME
      • 5.3.2.1 home market, 2015 - 2026 (USD Million)

Chapter 6 Artificial Insemination Market: Source Type Analysis

  • 6.1 Artificial Insemination Source Type Market Share Analysis, 2018 & 2026
  • 6.2 Artificial insemination Source Type Market: Segment Dashboard:
  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Source Type Segment
    • 6.3.1 AIH-HUSBAND
      • 6.3.1.1 AIH-Husband market, 2015 - 2026 (USD Million)
    • 6.3.2 AID-DONOR
      • 6.3.2.1 AID-Donor market, 2015 - 2026 (USD Million)

Chapter 7 Artificial Insemination Market: Regional Analysis

  • 7.1 Artificial Insemination Regional Market Share Analysis, 2018 & 2026
  • 7.2 Artificial Insemination Regional Market: Segment Dashboard
  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
  • 7.4 Market Size, & Forecasts, and Trend Analysis, 2015 to 2026
    • 7.4.1 North America
      • 7.4.1.1 North America Artificial insemination market, 2015 - 2026 (USD Million)
      • 7.4.1.1.1 U.S.
      • 7.4.1.1.1.1 U.S. Artificial insemination market, 2015 - 2026 (USD Million)
      • 7.4.1.1.2 Canada
      • 7.4.1.1.2.1 Canada Artificial insemination market, 2015 - 2026 (USD Million)
    • 7.4.2 Europe
      • 7.4.2.1 Europe Artificial insemination market, 2015 - 2026 (USD Million)
      • 7.4.2.1.1 U.K.
      • 7.4.2.1.1.1 U.K. Artificial insemination market, 2015 - 2026 (USD Million)
      • 7.4.2.1.2 Germany
      • 7.4.2.1.2.1 Germany Artificial insemination market, 2015 - 2026 (USD Million)
    • 7.4.3 Asia Pacific
      • 7.4.3.1 Asia Pacific Artificial insemination market, 2015 - 2026 (USD Million)
      • 7.4.3.1.1 Japan
      • 7.4.3.1.1.1 Japan Artificial insemination market, 2015 - 2026 (USD Million)
      • 7.4.3.1.2 China
      • 7.4.3.1.2.1 China Artificial insemination market, 2015 - 2026 (USD Million)
      • 7.4.3.1.3 India
      • 7.4.3.1.3.1 India Artificial insemination market, 2015 - 2026 (USD Million)
    • 7.4.4 Latin America
      • 7.4.4.1 Latin America Artificial insemination market, 2015 - 2026 (USD Million)
      • 7.4.4.1.1 Brazil
      • 7.4.4.1.1.1 Brazil Artificial insemination market, 2015 - 2026 (USD Million)
      • 7.4.4.1.2 Mexico
      • 7.4.4.1.2.1 Mexico Artificial insemination market, 2015 - 2026 (USD Million)
    • 7.4.5 Middle East And Africa (MEA)
      • 7.4.5.1 MEA Artificial insemination market, 2015 - 2026 (USD Million)
      • 7.4.5.1.1 South Africa
      • 7.4.5.1.1.1 South Africa Artificial insemination market, 2015 - 2026 (USD Million)

Chapter 8 Competitive Analysis

  • 8.1 Strategic Framework/ Competition Categorization (Key innovators, Market leaders, emerging players
  • 8.2 Company Profiles
    • 8.2.1 VITROLIFE
      • 8.2.1.1 Company overview
      • 8.2.1.2 Financial performance
      • 8.2.1.3 Product benchmarking
      • 8.2.1.4 Strategic initiatives
    • 8.2.2 GENEA LIMITED
      • 8.2.2.1 Company overview
      • 8.2.2.2 Product benchmarking
      • 8.2.2.3 Strategic initiatives
    • 8.2.3 RINOVUM WOMEN'S HEALTH, LLC
      • 8.2.3.1 Company Overview
      • 8.2.3.2 Product benchmarking
      • 8.2.3.3 STRATEGIC INITIATIVES
    • 8.2.4 PRIDE ANGEL
      • 8.2.4.1 Company overview
      • 8.2.4.2 Product benchmarking
    • 8.2.5 HI-TECH SOLUTIONS
      • 8.2.5.1 Company overview
      • 8.2.5.2 Product benchmarking
    • 8.2.6 FUJIFILM IRVINE SCIENTIFIC
      • 8.2.6.1 Company overview
      • 8.2.6.2 Product benchmarking
      • 8.2.6.3 Strategic initiatives
    • 8.2.7 KITAZATO CORPORATION
      • 8.2.7.1 Company overview
      • 8.2.7.2 Product benchmarking
      • 8.2.7.3 Strategic initiatives
    • 8.2.8 ROCKET MEDICAL PLC
      • 8.2.8.1 Company overview
      • 8.2.8.2 Product benchmarking

List of Tables

  • TABLE 1 List of secondary sources
  • TABLE 2 Occurrence of infertility among couples
  • TABLE 3 Factors affecting fertility
  • TABLE 4 Fertility rate, by region
  • TABLE 5 North America artificial insemination market, by country, 2015 - 2026 (USD Million)
  • TABLE 6 North America artificial insemination market, by type, 2015 - 2026 (USD Million)
  • TABLE 7 North America artificial insemination market, by end use, 2015 - 2026 (USD Million)
  • TABLE 8 North America artificial insemination market, by source type, 2015 - 2026 (USD Million)
  • TABLE 9 U.S. artificial insemination market, by type, 2015 - 2026 (USD Million)
  • TABLE 10 U.S. artificial insemination market, by end use, 2015 - 2026 (USD Million)
  • TABLE 11 U.S. artificial insemination market, by source type, 2015 - 2026 (USD Million)
  • TABLE 12 Canada artificial insemination market, by type, 2015 - 2026 (USD Million)
  • TABLE 13 Canada artificial insemination market, by end use, 2015 - 2026 (USD Million)
  • TABLE 14 Canada artificial insemination market, by source type, 2015 - 2026 (USD Million)
  • TABLE 15 Europe artificial insemination market, by country, 2015 - 2026 (USD Million)
  • TABLE 16 Europe artificial insemination market, by type, 2015 - 2026 (USD Million)
  • TABLE 17 Europe artificial insemination market, by end use, 2015 - 2026 (USD Million)
  • TABLE 18 Europe artificial insemination market, by source type, 2015 - 2026 (USD Million)
  • TABLE 19 U.K. artificial insemination market, by type, 2015 - 2026 (USD Million)
  • TABLE 20 U.K. artificial insemination market, by end use, 2015 - 2026 (USD Million)
  • TABLE 21 U.K. artificial insemination market, by source type, 2015 - 2026 (USD Million)
  • TABLE 22 Germany artificial insemination market, by type, 2015 - 2026 (USD Million)
  • TABLE 23 Germany artificial insemination market, by end use, 2015 - 2026 (USD Million)
  • TABLE 24 Germany artificial insemination market, by source type, 2015 - 2026 (USD Million)
  • TABLE 25 Asia Pacific artificial insemination market, by country, 2015 - 2026 (USD Million)
  • TABLE 26 Asia Pacific artificial insemination market, by type, 2015 - 2026 (USD Million)
  • TABLE 27 Asia Pacific artificial insemination market, by end use, 2015 - 2026 (USD Million)
  • TABLE 28 Asia Pacific artificial insemination market, by source type, 2015 - 2026 (USD Million)
  • TABLE 29 Japan artificial insemination market, by type, 2015 - 2026 (USD Million)
  • TABLE 30 Japan artificial insemination market, by end use, 2015 - 2026 (USD Million)
  • TABLE 31 Japan artificial insemination market, by source type, 2015 - 2026 (USD Million)
  • TABLE 32 China artificial insemination market, by type, 2015 - 2026 (USD Million)
  • TABLE 33 China artificial insemination market, by end use, 2015 - 2026 (USD Million)
  • TABLE 34 China artificial insemination market, by source type, 2015 - 2026 (USD Million)
  • TABLE 35 India artificial insemination market, by type, 2015 - 2026 (USD Million)
  • TABLE 36 India artificial insemination market, by end use, 2015 - 2026 (USD Million)
  • TABLE 37 India artificial insemination market, by source type, 2015 - 2026 (USD Million)
  • TABLE 38 Latin America artificial insemination market, by country, 2015 - 2026 (USD Million)
  • TABLE 39 Latin America artificial insemination market, by type, 2015 - 2026 (USD Million)
  • TABLE 40 Latin America artificial insemination market, by end use, 2015 - 2026 (USD Million)
  • TABLE 41 Latin America artificial insemination market, by source type, 2015 - 2026 (USD Million)
  • TABLE 42 Brazil artificial insemination market, by type, 2015 - 2026 (USD Million)
  • TABLE 43 Brazil artificial insemination market, by end use, 2015 - 2026 (USD Million)
  • TABLE 44 Brazil artificial insemination market, by source type, 2015 - 2026 (USD Million)
  • TABLE 45 Mexico artificial insemination market, by type, 2015 - 2026 (USD Million)
  • TABLE 46 Mexico artificial insemination market, by end use, 2015 - 2026 (USD Million)
  • TABLE 47 Mexico artificial insemination market, by source type, 2015 - 2026 (USD Million)
  • TABLE 48 MEA artificial insemination market, by country, 2015 - 2026 (USD Million)
  • TABLE 49 MEA artificial insemination market, by type, 2015 - 2026 (USD Million)
  • TABLE 50 MEA artificial insemination market, by end use, 2015 - 2026 (USD Million)
  • TABLE 51 MEA artificial insemination market, by source type, 2015 - 2026 (USD Million)
  • TABLE 52 South Africa artificial insemination market, by type, 2015 - 2026 (USD Million)
  • TABLE 53 South Africa artificial insemination market, by end use, 2015 - 2026 (USD Million)
  • TABLE 54 South Africa artificial insemination market, by source type, 2015 - 2026 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Artificial insemination market outlook, 2018
  • Fig. 9 Artificial insemination market segmentation
  • Fig. 10 Penetration & growth prospect mapping
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Artificial insemination market - PESTLE analysis
  • Fig. 14 Artificial insemination type market: Porter's five forces model
  • Fig. 15 Artificial insemination type market share analysis, 2018 & 2026
  • Fig. 16 Artificial insemination type market: Segment dashboard
  • Fig. 17 Intrauterine insemination market, 2015 - 2026 (USD Million)
  • Fig. 18 Intracervical insemination market, 2015 - 2026 (USD Million)
  • Fig. 19 Intravaginal insemination market, 2015 - 2026 (USD Million)
  • Fig. 20 Intratubal insemination market, 2015 - 2026 (USD Million)
  • Fig. 21 Artificial insemination end use market share analysis, 2018 & 2026
  • Fig. 22 Artificial insemination end use market: Segment dashboard
  • Fig. 23 Fertility clinics & other facilitiess market, 2015 - 2026 (USD Million)
  • Fig. 24 Home market, 2015 - 2026 (USD Million)
  • Fig. 25 Artificial insemination source type market share analysis, 2018 & 2026
  • Fig. 26 Artificial insemination source type market: Segment dashboard
  • Fig. 27 AIH-husband market, 2015 - 2026 (USD Million)
  • Fig. 28 AID-donor market, 2015 - 2026 (USD Million)
  • Fig. 29 Artificial insemination regional market share analysis, 2018 & 2026
  • Fig. 30 Artificial insemination regional market: Segment dashboard
  • Fig. 31 Regional market place: Key takeaways
  • Fig. 32 North America artificial insemination market, 2015 - 2026 (USD Million)
  • Fig. 33 U.S. artificial insemination market, 2015 - 2026 (USD Million)
  • Fig. 34 Canada artificial insemination market, 2015 - 2026 (USD Million)
  • Fig. 35 Europe artificial insemination market, 2015 - 2026 (USD Million)
  • Fig. 36 U.K. artificial insemination market, 2015 - 2026 (USD Million)
  • Fig. 37 Germany artificial insemination market, 2015 - 2026 (USD Million)
  • Fig. 38 Asia Pacific artificial insemination market, 2015 - 2026 (USD Million)
  • Fig. 39 Japan artificial insemination market, 2015 - 2026 (USD Million)
  • Fig. 40 China artificial insemination market, 2015 - 2026 (USD Million)
  • Fig. 41 India artificial insemination market, 2015 - 2026 (USD Million)
  • Fig. 42 Latin America artificial insemination market, 2015 - 2026 (USD Million)
  • Fig. 43 Brazil artificial insemination market, 2015 - 2026 (USD Million)
  • Fig. 44 Mexico artificial insemination market, 2015 - 2026 (USD Million)
  • Fig. 45 MEA artificial insemination market, 2015 - 2026 (USD Million)
  • Fig. 46 South Africa artificial insemination market, 2015 - 2026 (USD Million)
  • Fig. 47 Strategy framework
Back to Top